Stem Cell Res Ther. 2018 Feb 26;9(1):50. doi: 10.1186/s13287-018-0801-9.

Human mesenchymal stem cells in spheroids improve fertility in model animals with damaged endometrium.

Domnina A¹, Novikova P², Obidina J³, Fridlyanskaya I³, Alekseenko L³, Kozhukharova I³, Lyublinskaya O³, Zenin V³, Nikolsky N³.

Abstract

BACKGROUND:

Asherman's syndrome (AS) is one of the gynecological disorders caused by the destruction of the endometrium. For some cases of AS available surgical methods and hormonal therapy are ineffective. Stem cell transplantation may offer a potential alternative for AS cure.

METHODS:

Human endometrial mesenchymal stem cells (eMSC) organized in spheroids were transplanted in rats with damaged endometrium modeled on AS. Treatment response was defined as pregnancy outcome and litter size.

RESULTS:

Application of eMSC in spheroids significantly improved the rat fertility with the AS model. eMSC organized in spheroids retain all properties of eMSC in monolayer: growth characteristics, expression of CD markers, and differentiation potential. Synthesis of angiogenic and anti-inflammatory factors drastically increased in eMSC assembled into spheroids.

CONCLUSIONS:

Human endometrial mesenchymal stem cells (eMSC) can be successfully applied for Asherman's syndrome (AS) treatment in the rat model. eMSC organized in spheroids were more therapeutically effective than the cells in monolayer. After transplantation of eMSC in spheroids the pregnancy outcome and litter size in rats with AS was higher than in rats that received autologous rat bone marrow cells. It suggests the therapeutic plausibility of heterologous eMSC in case of failure to use autologous cells.